Literature DB >> 20116364

Structure and phase behavior of O-stearoylethanolamine: a combined calorimetric, spectroscopic and X-ray diffraction study.

Pradip K Tarafdar1, Musti J Swamy.   

Abstract

Recent studies show that O-acylethanolamines (OAEs), structural isomers of the putative stress-fighting lipids, namely N-acylethanolamines (NAEs), can be derived from NAEs and are present in biological membranes under physiological conditions. In view of this, we have synthesized O-stearoylethanolamine (OSEA) as a representative OAE and investigated its phase behavior and crystal structure. The thermotropic phase transitions of OSEA dispersed in water and in 150mM NaCl were characterized using calorimetric, spectroscopic, turbidimetric and X-ray diffraction studies. These studies have revealed that when dispersed in water OSEA undergoes a cooperative phase transition centered at 53.8 degrees C from an ordered gel phase to a micellar structure whereas in presence of 150mM NaCl the transition temperature increases to 55.8 degrees C and most likely the bilayer structure is retained above the phase transition. O-Stearoylethanolamine crystallized in the orthorhombic space group P2(1)2(1)2(1) with four symmetry-related molecules in the unit cell. Single-crystal X-ray diffraction studies show that OSEA molecules adopt a linear structure with all-trans conformation in the acyl chain region. The molecules are organized in a tail-to-tail fashion, similar to the arrangement in a bilayer membrane. These studies are relevant to understanding the role of salt on the phase properties of this new class of lipids. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20116364     DOI: 10.1016/j.bbamem.2010.01.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  1 in total

1.  3-Meth-oxy-3-oxopropanaminium chloride.

Authors:  Tobias Gruber; Christopher J Schofield; Amber L Thompson
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.